Emerging Europe

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

See Prices or Subscribe
Emerging Europe

Latest Emerging Europe Analysis

Industry Trend Analysis - Progressive Reimbursement Policies Will Attract Orphan Drugmakers - SEPT 2015

While Slovenia is currently missing crucial elements of the infrastructure needed to manage rare diseases, such as a national registry and broader screening policies, the country presents significant commercial opportunities for orphan drugmakers owing to its progressive reimbursement policies towards orphan drugs and patients with rare diseases.

READ FULL ARTICLE...